Stifel Nicolaus Issues Pessimistic Forecast for Colgate-Palmolive (NYSE:CL) Stock Price

Colgate-Palmolive (NYSE:CLGet Free Report) had its target price cut by research analysts at Stifel Nicolaus from $95.00 to $93.00 in a report issued on Monday,Benzinga reports. The brokerage presently has a “hold” rating on the stock. Stifel Nicolaus’ target price would suggest a potential upside of 7.44% from the company’s current price.

Other equities research analysts have also issued reports about the company. Wells Fargo & Company decreased their price objective on Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating for the company in a research report on Tuesday, January 7th. Morgan Stanley lowered their price objective on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday. Piper Sandler cut their target price on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada reissued a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research note on Wednesday, January 29th. Finally, UBS Group dropped their price target on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a research note on Thursday, January 16th. One research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have given a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $101.16.

Check Out Our Latest Stock Report on CL

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $86.56 on Monday. Colgate-Palmolive has a fifty-two week low of $82.68 and a fifty-two week high of $109.30. The firm’s 50 day simple moving average is $91.19 and its 200-day simple moving average is $97.07. The company has a debt-to-equity ratio of 9.46, a current ratio of 0.41 and a quick ratio of 0.26. The company has a market cap of $70.72 billion, a P/E ratio of 24.59, a price-to-earnings-growth ratio of 3.61 and a beta of 0.44.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period last year, the business posted $0.87 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive will post 3.74 EPS for the current year.

Hedge Funds Weigh In On Colgate-Palmolive

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Chicago Partners Investment Group LLC increased its holdings in shares of Colgate-Palmolive by 16.2% during the 4th quarter. Chicago Partners Investment Group LLC now owns 6,752 shares of the company’s stock worth $591,000 after purchasing an additional 943 shares during the period. Peak Financial Advisors LLC acquired a new position in Colgate-Palmolive in the 4th quarter valued at approximately $1,315,000. Gordian Advisors LLC bought a new stake in shares of Colgate-Palmolive in the 3rd quarter worth approximately $602,000. Carrera Capital Advisors grew its holdings in shares of Colgate-Palmolive by 23.1% during the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after purchasing an additional 7,353 shares in the last quarter. Finally, Fiduciary Alliance LLC bought a new stake in shares of Colgate-Palmolive during the fourth quarter valued at approximately $4,066,000. Institutional investors own 80.41% of the company’s stock.

About Colgate-Palmolive

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Further Reading

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.